Gerresheimer AG's revenue for the
three
months ended in Feb. 2024 was €466 Mil.
Its revenue for the trailing twelve months (TTM) ended in Feb. 2024 was €1,999 Mil.
Gerresheimer AG's Revenue per Share for the
three
months ended in Feb. 2024 was €13.50.
Its Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 was €58.63.
Warning Sign:
Gerresheimer AG revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Gerresheimer AG was -3.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 9.70% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 7.20% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 3.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Gerresheimer AG's highest 3-Year average Revenue per Share Growth Rate was 15.60% per year. The lowest was 0.40% per year. And the median was 2.80% per year.
Gerresheimer AG Revenue Historical Data
The historical data trend for Gerresheimer AG's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Gerresheimer AG's Revenue
For the Medical Instruments & Supplies subindustry, Gerresheimer AG's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gerresheimer AG's Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's Revenue distribution charts can be found below:
* The bar in red indicates where Gerresheimer AG's Revenue falls into.
Gerresheimer AG Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,999 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gerresheimer AG (XTER:GXI) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Gerresheimer AG Revenue Related Terms
Thank you for viewing the detailed overview of Gerresheimer AG's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTER:GXI has been successfully added to your 